Clinical Trial Update: D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating D-cycloserine augmentation of CBT for pediatric obsessive-compulsive disorder has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of South Florida | Conditions: Obsessive-compulsive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-01-23